Altered T-Cell Responses by the Periodontal Pathogen Porphyromonas gingivalis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Khalaf, Hazem ^a   Bengtsson, Torbjörn ^a  

^a ÖREBRO UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CATHEPSIN B INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; LEUPEPTIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIAL VIABILITY; BACTERIUM ADHERENCE; BIOACCUMULATION; CALCIUM TRANSPORT; CELL COMMUNICATION; CELLULAR IMMUNITY; CONTROLLED STUDY; GENETIC REGULATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE DYSREGULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; T LYMPHOCYTE;

ADHESINS, BACTERIAL; CALCIUM; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LEUPEPTINS; LUCIFERASES; MICROSCOPY, CONFOCAL; NF-KAPPA B; PORPHYROMONAS GINGIVALIS; PROTEOLYSIS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1;

PORPHYROMONAS GINGIVALIS;

EID: 84866342642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045192     Document Type: Article

References (43)

1. Tonetti MS, (2009) Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol 36Suppl 10: 15-19.
2. Hansson GK, Jonasson L, (2009) The discovery of cellular immunity in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol 29: 1714-1717.
3. Nilsson J, Wigren M, Shah PK, (2009) Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis. Trends Cardiovasc Med 19: 272-276.
4. Gemmell E, Yamazaki K, Seymour GJ, (2007) The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol 2000 43: 14-40.
5. Macian F, Im SH, Garcia-Cozar FJ, Rao A, (2004) T-cell anergy. Curr Opin Immunol 16: 209-216.
6. Okada T, Miller MJ, Parker I, Krummel MF, Neighbors M, et al. (2005) Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. PLoS Biol 3: e150.
7. Andrukhov O, Ulm C, Reischl H, Nguyen PQ, Matejka M, et al. (2011) Serum cytokine levels in periodontitis patients in relation to the bacterial load. J Periodontol 82: 885-892.
8. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, et al. (2006) Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12: 178-180.
9. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, et al. (1999) Protective role of interleukin-10 in atherosclerosis. Circ Res 85: e17-24.
10. Ross R, (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
11. Sasaki N, Yamashita T, Takeda M, Shinohara M, Nakajima K, et al. (2009) Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 120: 1996-2005.
12. Holt SC, Kesavalu L, Walker S, Genco CA, (1999) Virulence factors of Porphyromonas gingivalis. Periodontol 2000 20: 168-238.
13. Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, et al. (1995) Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 63: 3878-3885.
14. Deshpande RG, Khan MB, Genco CA, (1998) Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 66: 5337-5343.
15. Darveau RP, Belton CM, Reife RA, Lamont RJ, (1998) Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun 66: 1660-1665.
16. Kuramitsu HK, (1998) Proteases of Porphyromonas gingivalis: what don't they do? Oral Microbiol Immunol 13: 263-270.
17. Tam V, O'Brien-Simpson NM, Chen YY, Sanderson CJ, Kinnear B, et al. (2009) The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis Inactivate the Th2 cytokines interleukin-4 and interleukin-5. Infect Immun 77: 1451-1458.
18. Kobayashi-Sakamoto M, Isogai E, Hirose K, (2003) Porphyromonas gingivalis modulates the production of interleukin 8 and monocyte chemotactic protein 1 in human vascular endothelial cells. Curr Microbiol 46: 109-114.
19. Calkins CC, Platt K, Potempa J, Travis J, (1998) Inactivation of tumor necrosis factor-alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J Biol Chem 273: 6611-6614.
20. Grynkiewicz G, Poenie M, Tsien RY, (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450.
21. Cui J, Bian JS, Kagan A, McDonald TV, (2002) CaT1 contributes to the stores-operated calcium current in Jurkat T-lymphocytes. J Biol Chem 277: 47175-47183.
22. Quintana A, Kummerow C, Junker C, Becherer U, Hoth M, (2009) Morphological changes of T cells following formation of the immunological synapse modulate intracellular calcium signals. Cell Calcium 45: 109-122.
23. Patrussi L, Baldari CT, (2008) Intracellular mediators of CXCR4-dependent signaling in T cells. Immunol Lett 115: 75-82.
24. Pores-Fernando AT, Zweifach A, (2009) Calcium influx and signaling in cytotoxic T-lymphocyte lytic granule exocytosis. Immunol Rev 231: 160-173.
25. Aoki Y, Tabeta K, Murakami Y, Yoshimura F, Yamazaki K, (2010) Analysis of immunostimulatory activity of Porphyromonas gingivalis fimbriae conferred by Toll-like receptor 2. Biochem Biophys Res Commun 398: 86-91.
26. Shpacovitch VM, Brzoska T, Buddenkotte J, Stroh C, Sommerhoff CP, et al. (2002) Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J Invest Dermatol 118: 380-385.
27. Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, et al. (1998) Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 435: 45-48.
28. Sareila O, Kelkka T, Pizzolla A, Hultqvist M, Holmdahl R, (2011) NOX2 complex-derived ROS as immune regulators. Antioxid Redox Signal 15: 2197-2208.
29. Guo Y, Nguyen KA, Potempa J, (2010) Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontol 2000 54: 15-44.
30. Kitamura Y, Matono S, Aida Y, Hirofuji T, Maeda K, (2002) Gingipains in the culture supernatant of Porphyromonas gingivalis cleave CD4 and CD8 on human T cells. J Periodontal Res 37: 464-468.
31. Weinberg A, Belton CM, Park Y, Lamont RJ, (1997) Role of fimbriae in Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 65: 313-316.
32. Sugawara S, Nemoto E, Tada H, Miyake K, Imamura T, et al. (2000) Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness. J Immunol 165: 411-418.
33. Jagels MA, Travis J, Potempa J, Pike R, Hugli TE, (1996) Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect Immun 64: 1984-1991.
34. Khalaf H, Jass J, Olsson PE, (2010) Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells. BMC Immunol 11: 26.
35. Macian F, Lopez-Rodriguez C, Rao A, (2001) Partners in transcription: NFAT and AP-1. Oncogene 20: 2476-2489.
36. Jain J, Valge-Archer VE, Sinskey AJ, Rao A, (1992) The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter. J Exp Med 175: 853-862.
37. Belibasakis GN, Reddi D, Bostanci N, (2011) Porphyromonas gingivalis induces RANKL in T-cells. Inflammation 34: 133-138.
38. Oda T, Yoshie H, Yamazaki K, (2003) Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol Immunol 18: 30-36.
39. Pae HO, Oh GS, Choi BM, Chae SC, Kim YM, et al. (2004) Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 172: 4744-4751.
40. Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF, (2009) The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol Immunol 24: 11-17.
41. Kadowaki T, Nakayama K, Okamoto K, Abe N, Baba A, et al. (2000) Porphyromonas gingivalis proteinases as virulence determinants in progression of periodontal diseases. J Biochem 128: 153-159.
42. Yun LW, Decarlo AA, Hunter N, (2007) Blockade of protease-activated receptors on T cells correlates with altered proteolysis of CD27 by gingipains of Porphyromonas gingivalis. Clin Exp Immunol 150: 217-229.
43. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA, (2007) IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178: 2018-2027.